Showing 761 - 780 results of 1,061 for search '"lymphoma"', query time: 0.06s Refine Results
  1. 761

    Emerging Stem Cell Therapies: Treatment, Safety, and Biology by Joel Sng, Thomas Lufkin

    Published 2012-01-01
    “…Hematopoietic stem cell transplantation was the first example of a successful stem cell therapy and is widely utilized for treating various diseases including adult T-cell leukemia-lymphoma and multiple myeloma. The autologous transplantation of mesenchymal stem cells is increasingly employed to catalyze the repair of mesenchymal tissue and others, including the lung and heart, and utilized in treating various conditions such as stroke, multiple sclerosis, and diabetes. …”
    Get full text
    Article
  2. 762

    Persistent Hypoglycemia in Patient with Hodgkin’s Disease by Harold Cinco Lim, Lubna Bashir Munshi, David Sharon

    Published 2015-01-01
    “…Patient was suspected of having hypoglycemia related to lymphoma and was given a trial of prednisone which resolved the hypoglycemic episodes and made the patient euglycemic for the rest of his hospital stay. …”
    Get full text
    Article
  3. 763

    Effect of Meloxicam on the Proliferation and Apoptosis of the Raji Cell Line: an In Vitro Study by Yolanda Kartika Asmarani, null Supriatno, Tetiana Haniastuti

    Published 2022-01-01
    “…The objective of the research was to study the effect of meloxicam on the proliferation and apoptosis of Raji cell lines. Burkitt lymphoma (BL) cells (Raji ATCC CCL-86) were treated with various concentrations of meloxicam for 24 hours. …”
    Get full text
    Article
  4. 764

    Review of Methods for Detection Helicobacter pylori in Kazakhstan by Lavrinenko Alyona, Seisenbekova Aizhan, Turemuratova Aidana, Shkreba Alexey, Yukhnevich Yekaterina

    Published 2025-01-01
    “…ABSTRACT Helicobacter pylori (H. pylori) infection can cause a wide range of gastrointestinal disorders, including chronic nonatrophic gastritis, multifocal atrophic gastritis, peptic ulcer disease, gastric adenocarcinoma, and extra‐nodal B‐cell lymphoma. Although the prevalence of H. pylori infection has decreased among adults, it is still very common. …”
    Get full text
    Article
  5. 765

    Biclonal IgD and IgM Plasma Cell Myeloma: A Report of Two Cases and a Literature Review by Zhongchuan W. Chen, Ioanna Kotsikogianni, Jay S. Raval, Christine G. Roth, Marian A. Rollins-Raval

    Published 2013-01-01
    “…Biclonal plasma cell myelomas, while currently not well characterized in terms of their clinical behavior, should be distinguished from B-cell lymphoma with plasmacytic differentiation, given the different therapeutic implications. …”
    Get full text
    Article
  6. 766

    Splenic Lymphangioma Mimicking Lymphomatous Involvement: A Case Report with Review of the Literature by Neda Soleimani, Fatemeh Pouraminaee, Mohammad Hossein Anbardar, Ali Bahador, Benyamin Rahimi, Sahand Mohammadzadeh, Fatemeh Aghakhaninejad, Mohammad Farahmand, Mahsa Hasani

    Published 2023-01-01
    “…In this study, we present an 18-year-old man, with Burkitt’s lymphoma who underwent laparotomy and total splenectomy as a result of cystic lesions discovered accidentally during imaging with the final diagnosis of splenic lymphangioma after histopathological evaluation.…”
    Get full text
    Article
  7. 767

    Polypoid Carcinoma of the Oropharynx with Stromal Ossifying Myofibroblastic Proliferation: A Case Report and Literature Review by Marcello Filotico, Alessandro D’Amuri

    Published 2016-01-01
    “…Immunohistochemistry documented positivity for cytokeratins, epithelial membrane antigen, and P63 in the globoid elements beneath the necrotic rim; strong and diffuse expression of vimentin, smooth muscle actin, and CD99 and BCL2 in the spindle elements; and complete negativity for cytokeratin 5/6, high molecular weight cytokeratin (clone 34βE12), S100, muscle-specific actin, desmin, CD117, and anaplastic lymphoma kinase. The lesion was morphologically and immunophenotypically classified as a polypoid oropharyngeal carcinoma with ossifying myofibroblastic stromal proliferation.…”
    Get full text
    Article
  8. 768
  9. 769

    Hemorrhagic Cystitis due to BK Reactivation in a Young Female Treated for Hodgkin-Disease by R. Le Calloch, J. C. Ianotto, C. Berthou, A. Tempescul

    Published 2011-01-01
    “…Hodgkin's lymphoma is a disease with a high rate of curability under classic chemo-radiotherapy regimes. …”
    Get full text
    Article
  10. 770

    Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia by Ahmet B. Ergin, Nancy Fong, Hamed A. Daw

    Published 2012-01-01
    “…Here we present a case of an 82-year-old man who was treated with rituximab for recurrent marginal zone lymphoma. After the first infusion of rituximab, he reported fever, chills, and dyspnea. …”
    Get full text
    Article
  11. 771

    Plasmacytoid Urothelial Carcinoma of the Urinary Bladder Metastatic to the Duodenum: A Case Report—Diagnostic Relevance of GATA3 Immunohistochemistry by Hermann Brustmann

    Published 2017-01-01
    “…Since this tumor might be confused with plasmacytoma, lymphoma, or carcinoma variants, appropriate diagnosis in small biopsy samples could be challenging. …”
    Get full text
    Article
  12. 772

    Recurrent Inflammatory Myofibroblastic Tumor of Larynx Harboring a Novel THBS1::ALK Fusion by Namra Ajmal, Stacey M. Gargano, Ujwala Gosavi, Madalina Tuluc

    Published 2024-01-01
    “…The tumor demonstrated a novel THBS1::ALK fusion containing Exons 1–7 of the thrombospondin 1 (THBS1) gene fused to Exon 19 of the anaplastic lymphoma kinase (ALK) gene via next-generation sequencing with the NextSeq sequencer. …”
    Get full text
    Article
  13. 773

    The Conundrum of Septic Shock Imitators in Patients with Hematologic Cancers: Case Presentation and Possible Differential Diagnoses by Giorgio Berlot, Giulia Moratelli, Martina Tarchini, Katiuscia Battaglia, Paolo Grassi, Nadia Zarrillo, Vincenzo Colella, Rossana Bussani

    Published 2019-01-01
    “…The authors describe the case of a patient treated with several cycles of chemotherapy due to an advanced stage non-Hodgkin lymphoma. One daafter the last cycle, he was admitted to our Intensive Care Unit with a septic shock-like clinical picture which didn’t respond to the aggressive treatment and the patient died a few hours later. …”
    Get full text
    Article
  14. 774

    Identification of Bexarotene as a PPARγ Antagonist with HDX by David P. Marciano, Dana S. Kuruvilla, Bruce D. Pascal, Patrick R. Griffin

    Published 2015-01-01
    “…The retinoid x receptors (RXRs) are the pharmacological target of Bexarotene, an antineoplastic agent indicated for the treatment of cutaneous T cell lymphoma (CTCL). The RXRs form heterodimers with several nuclear receptors (NRs), including peroxisome proliferator-activated receptor gamma (PPARγ), to regulate target gene expression through cooperative recruitment of transcriptional machinery. …”
    Get full text
    Article
  15. 775

    Overview of the evaluation of the destructive effect of procarbazine on the ovarian reserve in the apoptotic, inflammatory, and oxidative pathways by Kezban Kartlasmis, Ayse Nur Cakir Gungor, Yurdun Kuyucu, Samet Kara

    Published 2024-12-01
    “…An important and effective chemotherapeutic drug, procarbazine is used to treat brain tumors and Hodgkin lymphoma in children, adolescents, and young adults. …”
    Get full text
    Article
  16. 776

    Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example by Ronan Foley, John Kuruvilla

    Published 2024-04-01
    “…Abstract Chimeric antigen receptor T cell (CAR-T) therapies targeting the CD19 antigen have been associated with high and durable response rates in patients with diffuse large B cell lymphoma (DLBCL). CAR-T cell therapies are commonly administered in the inpatient setting due to the average onset of cytokine release syndrome within the first 3 days post infusion, but there has been growing interest in delivering CAR-T cell therapies in the outpatient setting to overcome frequent hospital bed shortages and the high cost of inpatient care. …”
    Get full text
    Article
  17. 777

    Iatrogenic Pulmonary Nodule in a Heart Transplant Recipient by Atul C. Mehta, Juan Wang, Jarmanjeet Singh, Joseph Cicenia

    Published 2014-01-01
    “…A 58-year-old female with a history of non-Hodgkin lymphoma and end-stage nonischemic cardiomyopathy from Adriamycin toxicity underwent orthotic heart transplantation during June 2013. …”
    Get full text
    Article
  18. 778

    Secondary Hemophagocytic Syndrome Associated with Richter’s Transformation in Chronic Lymphocytic Leukemia by Nura El-Haj, Wilson I. Gonsalves, Vinay Gupta, Jacob P. Smeltzer, Sameer A. Parikh, Preet P. Singh, Naseema Gangat

    Published 2014-01-01
    “…We describe the first case of a CLL patient presenting with HPS due to acquisition of EBV-related large cell lymphoma in the setting of profound immunodeficiency.…”
    Get full text
    Article
  19. 779

    Case report: Musculoskeletal metastastic inflammatory myofibroblastic tumor (IMT) treated by sequential ALK-TKI with longterm response by Thomas Cochin, Sabine Noal, Dinu Stefan, Damien Bodet, Jérémie Rouger, Marine Dorbeau, Zoé Neviere

    Published 2025-01-01
    “…Inflammatory myofibroblastic tumors (IMTs) are known to be associated with rearrangements of the anaplastic lymphoma kinase (ALK) gene. The treatment of this type of tumor includes systemic therapies such as chemotherapies or anti-inflammatories; in recent years, targeted anti-ALK therapies have emerged and became the standard of care in ALK rearranged patients. …”
    Get full text
    Article
  20. 780

    Kikuchi-Fujimoto Disease: A Case Report and Literature Review by Vikrant Veer, Albert Lim, Wolfgang Issing

    Published 2012-01-01
    “…Further radiological scans showed a mass near the carotid and enlarged level V lymph nodes. Lymphoma was initially suspected. Fine-needle aspiration and excision biopsy were undertaken. …”
    Get full text
    Article